Sort
15,842 grants matching “pancreatic cancer”
DEFINING THE IMPACT OF KRAS MUTATIONAL HETEROGENEITY ON THE TUMOR MICROENVIRONMENT IN PANCREATIC CANCER
$720,375Weill Medical College Of Cornell University · · FY2025 · Defense Health Agency
PEPTIDE BEAD MICROARRAYS MEASURED BY MASS SPECTROMETRY IMAGING
$720,069Vladislav Bergo · Adeptrix Corporation · R44 · FY2016 · GM
Optimizing Ultrasound Enhanced Delivery of Therapeutics
$719,849Flemming Forsberg · Thomas Jefferson University · R01 · FY2016 · CA
Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer Markers
$719,834James Michael Pierce · University Of Georgia · U01 · FY2007 · CA
Probing cytosolic nucleic acid sensing pathways in cancer
$719,771Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Biomarkers for the Early Detection of Pancreatic Cancer
$718,942Ann M Killary · University Of Tx Md Anderson Can Ctr · U01 · FY2014 · CA
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer
$718,747Ajay Goel · Beckman Research Institute/City Of Hope · U01 · FY2020 · CA
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
$718,501William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$718,144John Blenis · Harvard Medical School · R37 · FY2010 · CA
Project 1: Physical modeling and dynamics of tumor cell migration mechanics
$717,814David J Odde · University Of Minnesota · U54 · FY2017 · CA
Dissecting the impact of tumor-intrinsic chromosomal instability on the cancer ecosystem
$717,795Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Mechanistic dissection and inhibitor targeting of autophagy in RAS driven cancers
$717,245Kirsten L Bryant · Univ Of North Carolina Chapel Hill · R37 · FY2025 · CA
Biomarkers to stratify pain severity and type in pancreatic disease
$716,188Hanno Steen · Boston Children'S Hospital · R01 · FY2025 · DK
Endoscopic Fine-Needle Polarized Scanning Spectroscopy for Pancreatic Cystic Lesions Diagnosis
$716,153Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2018 · EB
PANCREATIC CANCER RISK PREDICTED FROM ELECTRONIC HEALTH RECORDS IN U.S. VETERANS USING ARTIFICIAL INTELLIGENCE
$716,069President And Fellows Of Harvard College · · FY2025 · Defense Health Agency
Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors
$715,908Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Magnetic resonance Imaging as a Non-Invasive Method for Assessment of Pancreatic fibrosis (MINIMAP): a pilot study
$715,410Evan L Fogel · Indiana University Indianapolis · R01 · FY2018 · DK
MECHANISMS OF ANGIOGENESIS IN TRANSGENIC TUMORIGENESIS
$715,078Children'S Hospital Boston · R01 · FY2002 · CA
TARGETING ACQUIRED RESISTANCE TO KRAS INHIBITORS IN PANCREATIC CANCER
$714,966The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2025 · Defense Health Agency
Biomarkers for the Early Detection of Pancreatic Cancer
$714,901University Of Texas Md Anderson Can Ctr · U01 · FY2005 · CA
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer
$714,893Anna M Wu · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Molecular Mechanisms of Growth Factor Modulated Proliferation
$714,590William Farrar · Basic Sciences · Z01 · FY2007 · CA
Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimens
$714,330Rosalie C Sears · Oregon Health & Science University · U01 · FY2021 · CA
Investigating hypoxia as a determinant of malignant fates in pancreas cancer
$714,122Tuomas Tammela · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
NanoCytology to mitigate overdiagnosis of prostate cancer
$713,412Hariharan Subramanian · Nanocytomics, Llc · R44 · FY2016 · CA